CLINICAL_TRIALS
trial_result
· 2018-08-10
Clinical Trial Update: Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis [Phase 2]
Summary
Phase 2 trial update for dupilumab in adults with extrinsic moderate-to-severe atopic dermatitis completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2018-08-10